These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22158944)

  • 1. Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells.
    Arora HC; Jensen MP; Yuan Y; Wu A; Vogt S; Paunesku T; Woloschak GE
    Cancer Res; 2012 Feb; 72(3):769-78. PubMed ID: 22158944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded Fe
    Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
    J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen.
    Wang HW; Ma KL; Liu H; Zhou JY
    Aging (Albany NY); 2020 Apr; 12(7):6018-6029. PubMed ID: 32259795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
    Wang J; Bhattacharyya J; Mastria E; Chilkoti A
    J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
    Perche F; Patel NR; Torchilin VP
    J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
    Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C
    Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
    Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
    Zheng Z; Aojula H; Clarke D
    J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers.
    Huang W; Lang Y; Hakeem A; Lei Y; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1723-1736. PubMed ID: 29606866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
    Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
    Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.
    Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH
    Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.
    Hu Q; Wang Y; Xu L; Chen D; Cheng L
    Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors.
    Gazzano E; Rolando B; Chegaev K; Salaroglio IC; Kopecka J; Pedrini I; Saponara S; Sorge M; Buondonno I; Stella B; Marengo A; Valoti M; Brancaccio M; Fruttero R; Gasco A; Arpicco S; Riganti C
    J Control Release; 2018 Jan; 270():37-52. PubMed ID: 29191785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells.
    Ai S; Jia T; Ai W; Duan J; Liu Y; Chen J; Liu X; Yang F; Tian Y; Huang Z
    Br J Pharmacol; 2013 Apr; 168(7):1719-35. PubMed ID: 23146125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
    Kim D; Lee ES; Park K; Kwon IC; Bae YH
    Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Dong X; Mattingly CA; Tseng MT; Cho MJ; Liu Y; Adams VR; Mumper RJ
    Cancer Res; 2009 May; 69(9):3918-26. PubMed ID: 19383919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
    Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
    Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles.
    Chen Y; Wan Y; Wang Y; Zhang H; Jiao Z
    Int J Nanomedicine; 2011; 6():2321-6. PubMed ID: 22072869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.